US Edition
The Aemps, Co-Leader of the European Drug Repositioning Project
Summary by redaccionmedica.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Europe and Spain join forces in the pharmaceutical industry. The European Medicines Agency (EMA) and the Spanish Agency for Medicinal Products and Health Prodcutos (Aemps) have been instrumental in the preparation of the European drug repositioning pilot. This plan, which was drawn up between October 2021 and December 2024, already has its first results, which have been distributed by the health agencies on Thursday. From this, moreover, one con…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
